Virtual Panel Discussion

Thursday, February 17th, 2022, 4-5pm

Panelists from NIH's Rocky Mountain Laboratories discussed their research and answer questions about Covid-19, vaccines, and infectious disease research on Thursday, February 17 from 4-5pm. 

Rocky Mountain Laboratories (RML)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institutes of Health (NIH)

Katelyn Andersen, moderator, serves as the Well-being and Workplace Environment Facilitator for RML. She leads discussions to develop and coordinate programs focusing on well-being, teambuilding, and communication for staff. Katelyn also builds and maintains coalitions with community boards and organizations to improve relationships with RML staff and stakeholders. Katelyn serves on spectrUM's Bitterroot STEAM Advisory Committee.

Dr. Marshall Bloom received an MD from Washington University School of Medicine. He has studied viral infections at Rocky Mountain Labs for almost 50 years and has been Associate Director for Scientific Management at RML for the last 20 years. He serves as the principal public spokesperson for RML on a variety of topics.

Dr. Catharine (Katy) Bosio earned her Bachelor’s degree from Washington State University and PhD from Colorado State University.  She has more than 25 years’ experience studying immunity to bacterial and viral infections in the lungs. Katy is currently the Chief of the Immunity to Pulmonary Pathogens Section at NIAID, NIH.

Dr. Andrea Marzi received her M.Sc. and Ph.D. from the Friedrich-Alexander University in Erlangen, Germany. Her research is focused on the understanding of disease caused highly-pathogenic viruses like Ebola virus and the development of vaccines against these pathogens. Andrea is currently the Chief of the Immunobiology and Molecular Virology Unit at NIAID, NIH.

Dr. Karin Peterson earned her Ph.D. in Immunology from the University of Missouri School of Medicine.  Over the last 20 years, her research has focused on the interactions between immune responses and virus infections, particularly virus infections of the central nervous system.  She is currently the Chief of the Neuroimmunology Section at NIAID, NIH.

The views expressed during the virtual panel session are solely those of the panelists and do not necessarily represent the official views of the National Institutes of Health.